Every round on record, with the sources behind each and the investors on them.
A company founded on research conducted at the UB in the fields of neuropharmacology, neuroepigenetics and neurodegeneration
flaviitherapeutics.comBarcelona, SpainBiotechFounded 2025
2 sources · checked 2 times, last 3h ago
Developing: it holds up against its sources so far, and firms up as more reporting lands.
Sources agree. “Nearly €1 million” describes the same round approximately, not a separate financing total.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round | $949K €843,000 | 2026-10-17 | Grow Venture Partners | 2 outlets. #39 in Trending |
2 sources · checked 2 times, last 3h ago [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 2 sources Sources agree. “Nearly €1 million” describes the same round approximately, not a separate financing total. | ||||
Flavii Therapeutics develops epigenetic medicines for people with central nervous system disorders, including neurodegenerative and neurodevelopmental diseases.
Checked against 8 sources today
Also named as backers in company research: Knowledge Industry program (Seed, Product, Innovators)